Terumo Co. (OTCMKTS:TRUMY) Short Interest Up 217.4% in March

Terumo Co. (OTCMKTS:TRUMYGet Free Report) saw a large increase in short interest in March. As of March 31st, there was short interest totalling 61,900 shares, an increase of 217.4% from the March 15th total of 19,500 shares. Based on an average daily trading volume, of 213,100 shares, the days-to-cover ratio is currently 0.3 days. Approximately 0.0% of the company’s stock are sold short.

Terumo Stock Up 0.6 %

TRUMY stock traded up $0.11 during midday trading on Tuesday, hitting $18.87. The company’s stock had a trading volume of 213,423 shares, compared to its average volume of 197,557. Terumo has a 52-week low of $14.06 and a 52-week high of $21.22. The firm has a 50-day simple moving average of $18.33 and a 200-day simple moving average of $19.09. The company has a quick ratio of 1.70, a current ratio of 2.94 and a debt-to-equity ratio of 0.12. The firm has a market capitalization of $27.94 billion, a P/E ratio of 39.68 and a beta of 0.76.

Terumo (OTCMKTS:TRUMYGet Free Report) last released its earnings results on Thursday, February 13th. The company reported $0.16 earnings per share for the quarter. The firm had revenue of $1.73 billion for the quarter.

Terumo Company Profile

(Get Free Report)

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.

Featured Stories

Receive News & Ratings for Terumo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terumo and related companies with MarketBeat.com's FREE daily email newsletter.